- Home
- AACG vs PYPD Comparison
AACG vs PYPD Comparison
Compare AACG & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- PYPD
- Stock Information
- Founded
- AACG 1999
- PYPD 2008
- Country
- AACG China
- PYPD Israel
- Employees
- AACG N/A
- PYPD N/A
- Industry
- AACG Other Consumer Services
- PYPD Medical/Dental Instruments
- Sector
- AACG Real Estate
- PYPD Health Care
- Exchange
- AACG Nasdaq
- PYPD Nasdaq
- Market Cap
- AACG 27.1M
- PYPD 30.1M
- IPO Year
- AACG N/A
- PYPD 2020
- Fundamental
- Price
- AACG $0.87
- PYPD $2.71
- Analyst Decision
- AACG
- PYPD Strong Buy
- Analyst Count
- AACG 0
- PYPD 2
- Target Price
- AACG N/A
- PYPD $10.50
- AVG Volume (30 Days)
- AACG 40.9K
- PYPD 12.4K
- Earning Date
- AACG 05-13-2025
- PYPD 05-07-2025
- Dividend Yield
- AACG N/A
- PYPD N/A
- EPS Growth
- AACG N/A
- PYPD N/A
- EPS
- AACG N/A
- PYPD N/A
- Revenue
- AACG $36,725,098.00
- PYPD N/A
- Revenue This Year
- AACG N/A
- PYPD N/A
- Revenue Next Year
- AACG N/A
- PYPD N/A
- P/E Ratio
- AACG N/A
- PYPD N/A
- Revenue Growth
- AACG 20.95
- PYPD N/A
- 52 Week Low
- AACG $0.50
- PYPD $2.37
- 52 Week High
- AACG $1.16
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- AACG 42.35
- PYPD 42.57
- Support Level
- AACG $0.93
- PYPD $2.66
- Resistance Level
- AACG $1.03
- PYPD $2.75
- Average True Range (ATR)
- AACG 0.06
- PYPD 0.12
- MACD
- AACG -0.01
- PYPD -0.01
- Stochastic Oscillator
- AACG 23.81
- PYPD 11.48
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.